Transforming medicines value: a collaborative, data-driven approach
Hospital Pharmacy Europe
JULY 14, 2025
million people, secondary care drug costs rose to £668m in 2024/25, increasing at an average rate of 10% annually. With several high-cost biological medicines due to lose patent exclusivity by 2028, NHS England has identified a £1bn savings opportunity. In the Northeast and North Cumbria (NENC) region, which serves 3.2
Let's personalize your content